Major Ozonated Autohemotherapy Promotes the Recovery of Upper Limb Motor Function in Patients with Acute Cerebral Infarction

Overview

Journal Neural Regen Res

Date 2014 Sep 11

PMID 25206688

Citations 12

Authors

Xiaona Wu

Zhensheng Li

Xiaoyan Liu

Haiyan Peng

Yongjun Huang

Gaoquan Luo

Kairun Peng

Affiliations

Soon will be listed here.

Abstract

Major ozonated autohemotherapy is classically used in treating ischemic disorder of the lower limbs. In the present study, we performed major ozonated autohemotherapy treatment in patients with acute cerebral infarction, and assessed outcomes according to the U.S. National Institutes of Health Stroke Score, Modified Rankin Scale, and transcranial magnetic stimulation motor-evoked potential. Compared with the control group, the clinical total effective rate and the cortical potential rise rate of the upper limbs were significantly higher, the central motor conduction time of upper limb was significantly shorter, and the upper limb motor-evoked potential amplitude was significantly increased, in the ozone group. In the ozone group, the National Institutes of Health Stroke Score was positively correlated with the central motor conduction time and the motor-evoked potential amplitude of the upper limb. Central motor conduction time and motor-evoked potential amplitude of the upper limb may be effective indicators of motor-evoked potentials to assess upper limb motor function in cerebral infarct patients. Furthermore, major ozonated autohemotherapy may promote motor function recovery of the upper limb in patients with acute cerebral infarction.

Citing Articles

Effects of major air pollutants on angina hospitalizations: a correlation study.

Zhu A, Cao Y, Li C, Yu J, Liu M, Xu K BMC Public Health. 2024; 24(1):1877.

PMID: 39004712 PMC: 11247793. DOI: 10.1186/s12889-024-19380-2.

Ozone Improves Oxygenation and Offers Organ Protection after Autologous Blood Transfusion in a Simulated Carbon Dioxide Pneumoperitoneal Environment in a Rabbit Hemorrhagic Shock Model.

Gan Y, Tian X, Yao H, Huo F, Feng Y Transfus Med Hemother. 2024; 51(3):164-174.

PMID: 38867809 PMC: 11166905. DOI: 10.1159/000527934.

Effects of adjuvant ozone autohemotherapy combined with routine treatment on clinical and paraclinical features of mechanically ventilated COVID-19 patients in the intensive care unit: a pilot randomized controlled trial.

Aghamohammadi D, Shakouri S, Jahanpanah N, Dolatkhah N Med Gas Res. 2023; 14(2):67-74.

PMID: 37929510 PMC: 10715328. DOI: 10.4103/2045-9912.385439.

Ozone dialysis delivers three or more times the ozone than other forms of ozone blood treatment.

Rowen R, Grabovac S, Su T Med Gas Res. 2022; 13(2):67-71.

PMID: 36204785 PMC: 9555023. DOI: 10.4103/2045-9912.356474.

Ozone high dose therapy (OHT) improves mitochondrial bioenergetics in peripheral blood mononuclear cells.

Konig B, Lahodny J Transl Med Commun. 2022; 7(1):17.

PMID: 35880042 PMC: 9301618. DOI: 10.1186/s41231-022-00123-7.

References

Romero Valdes A, Menendez Cepero S, Gomez Moraleda M, Ley Pozo J . [Ozone therapy in the advanced stages of arteriosclerosis obliterans]. Angiologia. 1993; 45(4):146-8. View

Giunta R, Coppola A, Luongo C, Sammartino A, Guastafierro S, Grassia A . Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Ann Hematol. 2002; 80(12):745-8. DOI: 10.1007/s002770100377. View

Valacchi G, Bocci V . Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets. Mediators Inflamm. 2000; 8(4-5):205-9. PMC: 1781810. DOI: 10.1080/09629359990360. View

Koca K, Yurttas Y, Bilgic S, Cayci T, Topal T, Durusu M . Effect of preconditioned hyperbaric oxygen and ozone on ischemia-reperfusion induced tourniquet in skeletal bone of rats. J Surg Res. 2010; 164(1):e83-9. DOI: 10.1016/j.jss.2010.06.030. View

Bocci V, Zanardi I, Huijberts M, Travagli V . Diabetes and chronic oxidative stress. A perspective based on the possible usefulness of ozone therapy. Diabetes Metab Syndr. 2012; 5(1):45-9. DOI: 10.1016/j.dsx.2010.05.014. View

Clavo B, Catala L, Perez J, Rodriguez V, Robaina F . Ozone Therapy on Cerebral Blood Flow: A Preliminary Report. Evid Based Complement Alternat Med. 2005; 1(3):315-319. PMC: 538510. DOI: 10.1093/ecam/neh039. View

Lai S, Duncan P . Stroke recovery profile and the Modified Rankin assessment. Neuroepidemiology. 2001; 20(1):26-30. DOI: 10.1159/000054754. View

Tylicki L, Niew glowski T, Biedunkiewicz B, Burakowski S, Rutkowski B . Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs--pilot study. Int J Artif Organs. 2001; 24(2):79-82. View

Biedunkiewicz B, Tylicki L, Nieweglowski T, Burakowski S, Rutkowski B . Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: an oxygen-controlled study. Int J Artif Organs. 2004; 27(1):29-34. DOI: 10.1177/039139880402700107. View

10.

Bocci V . The case for oxygen-ozonetherapy. Br J Biomed Sci. 2007; 64(1):44-9. DOI: 10.1080/09674845.2007.11732755. View

11.

Monte A, van der Zee H, Bocci V . Major ozonated autohemotherapy in chronic limb ischemia with ulcerations. J Altern Complement Med. 2005; 11(2):363-7. DOI: 10.1089/acm.2005.11.363. View

12.

Marfella R, Luongo C, Coppola A, Luongo M, Capodanno P, Ruggiero R . Use of a non-specific immunomodulation therapy as a therapeutic vasculogenesis strategy in no-option critical limb ischemia patients. Atherosclerosis. 2009; 208(2):473-9. DOI: 10.1016/j.atherosclerosis.2009.08.005. View

13.

Adams Jr H, Adams R, Brott T, Del Zoppo G, Furlan A, Goldstein L . Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003; 34(4):1056-83. DOI: 10.1161/01.STR.0000064841.47697.22. View

14.

Clavo B, Perez J, Lopez L, Suarez G, Lloret M, Rodriguez V . Effect of ozone therapy on muscle oxygenation. J Altern Complement Med. 2003; 9(2):251-6. DOI: 10.1089/10755530360623365. View

15.

Calunga J, Trujillo Y, Menendez S, Zamora Z, Alonso Y, Merino N . Ozone oxidative post-conditioning in acute renal failure. J Pharm Pharmacol. 2009; 61(2):221-7. DOI: 10.1211/jpp/61.02.0012. View

16.

Catano A, Houa M, Caroyer J, Ducarne H, Noel P . Magnetic transcranial stimulation in non-haemorrhagic sylvian strokes: interest of facilitation for early functional prognosis. Electroencephalogr Clin Neurophysiol. 1995; 97(6):349-54. DOI: 10.1016/0924-980x(95)00127-7. View

17.

Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H . Ozone oxidative preconditioning protects the rat kidney from reperfusion injury: the role of nitric oxide. J Surg Res. 2008; 149(2):287-95. DOI: 10.1016/j.jss.2007.12.756. View

18.

Heald A, Bates D, Cartlidge N, French J, Miller S . Longitudinal study of central motor conduction time following stroke. 2. Central motor conduction measured within 72 h after stroke as a predictor of functional outcome at 12 months. Brain. 1993; 116 ( Pt 6):1371-85. DOI: 10.1093/brain/116.6.1371. View

19.

Watanabe T, Egawa M . Effects of an antistroke agent MCl-186 on cerebral arachidonate cascade. J Pharmacol Exp Ther. 1994; 271(3):1624-9. View

20.

Ferbert A, Vielhaber S, Meincke U, Buchner H . Transcranial magnetic stimulation in pontine infarction: correlation to degree of paresis. J Neurol Neurosurg Psychiatry. 1992; 55(4):294-9. PMC: 489042. DOI: 10.1136/jnnp.55.4.294. View